Effects of Treatment with Liraglutide Early after Surgical Intervention on Clinical Outcomes in Patients with Short Bowel Syndrome: A Pilot Observational “Real-Life” Study

Liraglutide, a glucagon-like peptide-1 agonist, has been shown to have beneficial effects on fecal output in short bowel syndrome (SBS) by small human studies. Its potential effects early after gut resection are not known. In this pilot observational study, we described the 1- and 6-month liraglutid...

Descripción completa

Detalles Bibliográficos
Autores principales: Merlo, Fabio Dario, Aimasso, Umberto, Ossola, Marta, Ippolito, Mirko, Cravero, Leila, Ponzo, Valentina, Bo, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305110/
https://www.ncbi.nlm.nih.gov/pubmed/37375644
http://dx.doi.org/10.3390/nu15122740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305110/
https://www.ncbi.nlm.nih.gov/pubmed/37375644
http://dx.doi.org/10.3390/nu15122740

Ejemplares similares